BIOMAT Database Logo BIOMAT Database Logo

Synthesis, Pim kinase inhibitory potencies and in vitro antiproliferative activities of diversely substituted pyrrolo[2,3-a]carbazoles. 2010

Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Clermont Université, Université Blaise Pascal, SEESIB, BP10448, F-63000 Clermont-Ferrand, France.

The synthesis of new pyrrolo[2,3-a]carbazole derivatives diversely substituted at the C-6 to C-9 positions is described. These compounds were tested for their kinase inhibitory potencies toward three kinases (Pim-1, Pim-2, Pim-3) as well as for their in vitro antiproliferative activities toward a human fibroblast primary culture and three human solid cancer cell lines (PC3, DU145, and PA 1). Moreover, molecular docking studies were performed to explain the enhanced inhibitory activity of the most active compound 3d.

UI MeSH Term Description Entries
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein

Related Publications

Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives.
June 2012, Bioorganic & medicinal chemistry letters,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.
October 2009, Journal of medicinal chemistry,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.
July 2011, Journal of medicinal chemistry,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives.
September 2008, Anti-cancer drugs,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
In-vitro antiproliferative activities and kinase inhibitory potencies of glycosyl-isoindigo derivatives.
October 2007, Anti-cancer drugs,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Synthesis and antiproliferative activities of diversely substituted glycosyl-isoindigo derivatives.
January 2006, European journal of medicinal chemistry,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling.
June 2009, European journal of medicinal chemistry,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles.
April 2024, European journal of medicinal chemistry,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Synthesis and in vitro antiproliferative activity of C5-benzyl substituted 2-amino-pyrrolo[2,3-d]pyrimidines as potent Hsp90 inhibitors.
January 2017, Bioorganic & medicinal chemistry letters,
Rufine Akué-Gédu, and Lionel Nauton, and Vincent Théry, and Jenny Bain, and Philip Cohen, and Fabrice Anizon, and Pascale Moreau
Synthesis and in vitro EGFR (ErbB1) tyrosine kinase inhibitory activity of 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines.
December 2011, European journal of medicinal chemistry,
Copied contents to your clipboard!